With Color Health CEO & Co-founder Othman Laraki With Color Health CEO & Co-founder Othman Laraki Most AI in healthcare promises superintelligencebut what if thats the wrong goal entirely
The drug "changes our brain's perception of taste so the same taste is not enjoyable anymore," he said
They are derived from patterns observed across hundreds of trial participants and from the pharmacological profile of the drug
They may adjust your treatment plan
We utilize cutting-edge treatments like GLP-1 medications combined with personalized lifestyle support and coaching
Retatrutide is widely studied as a triple receptor agonist, engaging GLP-1, GIP, and glucagon pathways linked to metabolic regulation, appetite signalling, energy balance, glucose metabolism, lipid utilisation, and body composition research